Scientific Sessions 2024  /  Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease  /  Leveraging GWAS to Identify Novel Drug Targets
Logo

American Heart Association

  119
  0

Final ID:

Leveraging GWAS to Identify Novel Drug Targets

  • Bouatia-naji, Nabila  ( PARCC- INSERM UMR970 , Paris , France )
  • Ganesh, Santhi  ( INTERNAL MEDICINE/DIV CARDIO MED , Ann Arbor , Michigan , United States )
    • Author Disclosures:
    Nabila Bouatia-Naji: DO NOT have relevant financial relationships | Santhi Ganesh: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
Precision-Based Small Molecule Therapeutics

Ho Carolyn, Ahmad Ferhaan

siRNA for Treatment of Hypertension

Desai Akshay, Bakris George

More abstracts from these authors:
Mapping the genetics of FMD and SCAD: Matricellular effects in arterial dysplasia and dissections

Ganesh Santhi

Vascular MAPK/ERK Activation in sFTL-1-Induced Preeclampsia In Vivo

Kumar Nitin, Hunker Kristina, Ganesh Santhi

You have to be authorized to contact abstract author. Please, Login
Not Available